Skip to main content

Table 2 Classification of funding source and competing interests in the included systematic reviews

From: Identifying competing interest disclosures in systematic reviews of surgical interventions and devices: a cross-sectional survey

 

Overall

(n = 155)

CSR

(n = 25)

Non-CSR

(n = 130)

Source of funding

 Industry funding

3 (1.9)

0 (0)

3 (2.3)

 Non-industry funding

42 (27.1)

20 (80.0)

22 (16.9)

 Industry + non-industry funding

1 (0.6)

0 (0)

1 (0.8)

 Reported as not funded

45 (29.0)

1 (4.0)

44 (33.8)

 Not reported

64 (41.3)

4 (16.0)

60 (46.2)

Types of competing interests

 No competing interest to disclose

111 (71.6)

12 (48.0)

99 (76.2)

At least one type

 Grant/fellowship

17 (11.0)

6 (24.0)

11 (8.5)

 Honoraria

15 (9.7)

2 (8.0)

13 (1.0)

 Consulting

14 (9.0)

4 (16.0)

10 (7.7)

 Non-monetary support

8 (5.2)

5 (20.0)

3 (2.3)

 Service in other affiliations

8 (5.2)

2 (8.0)

6 (4.6)

 Equity/stocks/bonds

3 (1.9)

1 (4.0)

2 (1.5)

 Patent

2 (1.3)

0 (0)

2 (1.5)

 Employment/salary

1 (0.6)

1 (4.0)

0 (0)

 Leadership in company

1 (0.6)

0 (0)

1 (0.8)

  Intellectual beliefs

6 (3.8)

4 (16.0)

2 (1.5)

 Experience

3 (1.9)

2 (8.0)

1 (0.8)

 Personal relationship

2 (1.3)

2 (8.0)

0 (0)

  1. Values in parentheses are percentages
  2. CSR Cochrane systematic review